Literature DB >> 355152

Chromosome 14 translocations in non-Burkitt lymphomas.

S Fukuhara, J D Rowley.   

Abstract

Chromosome studies were performed on malignant cells obtained from 27 patients with non-Burkitt lymphomas. A marker chromosome affecting the long arm of No. 14 (14q+) was the single most frequent abnormality and was noted in 17 of these patients. The frequency of the 14q+ marker varied with the type of lymphoma. For patients with malignant lymphoma, histiocytic, the frequency was 5 of 8; for mixed-cell type, 1 of 3; for poorly differentiated lymphocytic, 8 of 8; for well-differentiated lymphocytic, 0 of 3; for lymphoblastic, 0 of 1; for Hodgkin's disease, 2 of 3; and for mycosis fungoides, 1 of 1. The donor chromosome involved in the 14q translocation was identified in 12 cases; certain chromosomes appeared to be affected more frequently than others. Although the break point was band 14q32 in most cases, the exact location of the receptor site on 14q was not always consistent. The distal part of 14q24 was also involved as a receptor site in at least one translocation. These findings suggest that, in some types of lymphoid malignancy, cells with a 14q translocation have a proliferative advantage over cells with other chromosome rearrangments. The presence of the 14q translocation may be important in the future for the distinction among morphologically different, but functionally comparable, subgroups of lymphoid malignancies.

Entities:  

Mesh:

Year:  1978        PMID: 355152     DOI: 10.1002/ijc.2910220105

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Dysregulation of BCL-2 family proteins by leukemia fusion genes.

Authors:  Lauren M Brown; Diane T Hanna; Seong L Khaw; Paul G Ekert
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

Review 2.  Viewing BCL2 and cell death control from an evolutionary perspective.

Authors:  Andreas Strasser; David L Vaux
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

3.  Karyotype analysis of B-lymphocytes transformed by Epstein-Barr virus in 21 patients with B cell chronic lymphocytic leukemia.

Authors:  M Vahdati; H Graafland; J M Emberger
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

Review 4.  Epstein-Barr virus (EBV), lymphocytes and transformation.

Authors:  J Zeuthen
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome.

Authors:  R I Fox; T C Adamson; S Fong; C A Robinson; E L Morgan; J A Robb; F V Howell
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

Authors:  S E Shackney; A M Levine; R I Fisher; P Nichols; E Jaffe; W H Schuette; R Simon; C A Smith; S J Occhipinti; J W Parker
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Cytogenetic findings in T-zone lymphoma.

Authors:  E Gödde-Salz; E W Schwarze; H Stein; K Lennert; W Grote
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

8.  The chromosome changes in non-Burkitt lymphomas.

Authors:  B R Reeves; V L Pickup
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

9.  Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.

Authors:  H Ohno; T Furukawa; S Fukuhara; S Q Zong; H Kamesaki; T B Shows; M M Le Beau; T W McKeithan; T Kawakami; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Dual parameter flow cytometry studies in human lymphomas.

Authors:  S E Shackney; K S Skramstad; R E Cunningham; D J Dugas; T L Lincoln; R J Lukes
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.